Search results

1. Verastem spoils its ASCO bounce

   … patients as well as those with KRAS-mutant disease. ASCO 2024 In mid-2020 Verastem bought avutometinib, a …

   
    

   Jacob Plieth
    
   - 05/29/2024 - 13:14

2. ASCO 2024 abstract movers – Merus convinces, at first

   ASCO 2024 abstract movers – Merus convinces, at first …

   
    

   Jacob Plieth
    
   - 05/29/2024 - 14:20

3. ASCO 2024 preview – toxicity looms large for J&J

   ASCO 2024 preview – toxicity looms large for J&J …

   
    

   Madeleine Armstrong
    
   - 05/24/2024 - 15:51

4. ASCO 2024 preview – more questions for BioNTech

   ASCO 2024 preview – more questions for BioNTech … 33% Note: cutoff date 9 January 2024. Source: ASCO 2024 abstract.   This could come at a cost, … 63% Note: cutoff date 20 December 2023. Source: ASCO 2024 abstract.   In the second line, results …

   
    

   Madeleine Armstrong
    
   - 05/23/2024 - 22:58

5. ASCO 2024 preview – Merus’s home run remains unconfirmed

   ASCO 2024 preview – Merus’s home run remains unconfirmed …

   
    

   Jacob Plieth
    
   - 05/23/2024 - 23:02

6. ASCO 2024 preview – waiting for Blueprint and Caribou

   ASCO 2024 preview – waiting for Blueprint and Caribou …

   
    

   Madeleine Armstrong
    
   - 05/23/2024 - 22:59

7. ASCO 2024 preview – new Car-T target shows liver cancer promise

   ASCO 2024 preview – new Car-T target shows liver cancer …

   
    

   Jacob Plieth
    
   - 05/23/2024 - 22:54

8. ASCO 2024 preview – first look at Kelun’s registrational TROP2 dataset

   ASCO 2024 preview – first look at Kelun’s registrational …

   
    

   Jacob Plieth
    
   - 05/23/2024 - 22:58

9. ASCO 2024 preview – two strikes against USP1

   ASCO 2024 preview – two strikes against USP1 …

   
    

   Jacob Plieth
    
   - 05/24/2024 - 16:27

10. ASCO 2024 preview – jury still out on AbbVie's cancer push

    ASCO 2024 preview – jury still out on AbbVie's cancer push …

    
     

    Madeleine Armstrong
     
    - 05/28/2024 - 10:30